Stock Taper Organic Sales Growth: 5% year-over-year.
Adjusted EBITDA Margin: Expanded by 70 basis points to 28.1%.
Adjusted EPS: Increased by 12% to $2.32, exceeding guidance of $2.07 to $2.12.
Orders Growth: 28% organic growth, with Health & Science Technologies (HST) leading at 47%.
Free Cash Flow: Generated $177 million in Q2.
Share Repurchases: $77 million spent in Q2, maintaining a commitment to this level for the remainder of 2026.
Market Focus: Strong demand in data center, semiconductor, and space & defense markets, contributing to HST's growth.
Operational Execution: Improved throughput and supply chain readiness, alongside investments in capacity expansions.
8020 Initiative: Continued implementation to optimize resource allocation towards high-growth opportunities.
Segment Performance:
HST: 47% organic order growth; margin expansion driven by volume leverage.
Fluid & Metering Technologies (FMT): 11% order growth; 1% sales growth; margin decline attributed to unfavorable mix.
Fire & Safety (FSDP): 19% order growth; slight sales decline due to reduced activity in certain markets.
2026 Organic Growth: Revised upward to 5% to 6%, from a previous range of 3% to 4%.
Adjusted EBITDA Margin: Expected to range between 27% and 27.3%.
Adjusted EPS Guidance: Increased to $8.70 to $8.85, indicating high single-digit to low double-digit growth year-over-year.
Q3 2026 Expectations: Anticipate 5% to 7% organic growth, adjusted EBITDA margin of 27% to 27.5%, and adjusted EPS of $2.20 to $2.25.
Impact of IEEPA Tariff Refunds: While beneficial in the quarter, the refunds slightly reduced organic growth by 2% and may require future customer rebates.
FSDP Sales Decline: Experienced a 1% decline in sales, indicating potential softness in certain markets.
Geopolitical and Economic Uncertainty: Concerns regarding inflation, interest rates, and geopolitical tensions affecting customer sentiment and order patterns.
Order Dynamics: There is a shift towards longer lead-time orders, particularly in HST, indicating a more stable demand outlook.
Geographic Performance: North America remains the strongest market, with steady performance in Europe and growth in India, while China shows softer economic conditions.
Future M&A Activity: The company is exploring bolt-on acquisitions to enhance growth platforms, with a focus on proprietary conversations rather than large-scale mergers.
Incremental Margin Expectations: Higher margins are anticipated in HST due to a favorable mix of higher-margin businesses and ongoing productivity improvements. Overall, IDEX demonstrated strong performance in Q2 2026, with positive growth metrics and a favorable outlook, despite some challenges related to market conditions and tariff impacts. The company is strategically positioned to leverage its strengths in high-growth sectors while maintaining a disciplined approach to capital allocation.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT